124 related articles for article (PubMed ID: 9453997)
21. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization.
Artunc FH; Fischer IU; Risler T; Erley CM
Int J Cardiol; 2005 Jul; 102(2):173-8. PubMed ID: 15982481
[TBL] [Abstract][Full Text] [Related]
22. Comparison of renal function markers in Kuwaiti patients with sickle cell disease.
Marouf R; Mojiminiyi O; Abdella N; Kortom M; Al Wazzan H
J Clin Pathol; 2006 Apr; 59(4):345-51. PubMed ID: 16567469
[TBL] [Abstract][Full Text] [Related]
23. Serum cystatin C level as a potentially good marker for impaired kidney function.
Uzun H; Ozmen Keles M; Ataman R; Aydin S; Kalender B; Uslu E; Simsek G; Halac M; Kaya S
Clin Biochem; 2005 Sep; 38(9):792-8. PubMed ID: 16005452
[TBL] [Abstract][Full Text] [Related]
24. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
25. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
Sterner G; Björk J; Carlson J; Grubb A; Nyman U
Scand J Urol Nephrol; 2009; 43(3):242-9. PubMed ID: 19291590
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.
Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M
Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770
[TBL] [Abstract][Full Text] [Related]
27. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
Fontseré N; Salinas I; Bonal J; Bayés B; Riba J; Torres F; Rios J; Sanmartí A; Romero R
Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
[TBL] [Abstract][Full Text] [Related]
29. Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy.
Huhtala ML; Kahanpää K; Seppälä M; Halila H; Stenman UH
Int J Cancer; 1983 Jun; 31(6):711-4. PubMed ID: 6190763
[TBL] [Abstract][Full Text] [Related]
30. Validation of the Virga GFR equation in a renal transplant population.
Zahran A; Hossain MA; Kora MA; Galal AZ; Shoker A
Nephron Clin Pract; 2008; 109(3):c140-7. PubMed ID: 18663326
[TBL] [Abstract][Full Text] [Related]
31. Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.
Visvardis G; Griveas I; Zilidou R; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Pavlitou A; Sakellariou G
Transplant Proc; 2004; 36(6):1757-9. PubMed ID: 15350470
[TBL] [Abstract][Full Text] [Related]
32. Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status.
Wasén E; Isoaho R; Vahlberg T; Kivelä SL; Irjala K
Scand J Clin Lab Invest; 2008; 68(6):484-91. PubMed ID: 18609082
[TBL] [Abstract][Full Text] [Related]
33. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
[TBL] [Abstract][Full Text] [Related]
34. Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
Paju A; Jacobsen J; Rasmuson T; Stenman UH; Ljungberg B
J Urol; 2001 Mar; 165(3):959-62. PubMed ID: 11176522
[TBL] [Abstract][Full Text] [Related]
35. The correlation of renal allograft weight to metabolic index ratios and glomerular filtration rate among living-unrelated kidney transplant patients: a cross-sectional study.
Amante AJ; Piñon-Barretto SC
Transplant Proc; 2008 Sep; 40(7):2313-8. PubMed ID: 18790222
[TBL] [Abstract][Full Text] [Related]
36. Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin.
John GT; Fleming JJ; Talaulikar GS; Selvakumar R; Thomas PP; Jacob CK
Ann Clin Biochem; 2003 Nov; 40(Pt 6):656-8. PubMed ID: 14629804
[TBL] [Abstract][Full Text] [Related]
37. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.
Smilde TD; van Veldhuisen DJ; Navis G; Voors AA; Hillege HL
Circulation; 2006 Oct; 114(15):1572-80. PubMed ID: 17015793
[TBL] [Abstract][Full Text] [Related]
38. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
[TBL] [Abstract][Full Text] [Related]
39. Serum cystatin C as an index of renal function in kidney transplant patients.
Akbas SH; Yavuz A; Tuncer M; Ruhi C; Gurkan A; Cetinkaya R; Demirbas A; Gultekin M; Akaydin M; Ersoy F
Transplant Proc; 2004; 36(1):99-101. PubMed ID: 15013312
[TBL] [Abstract][Full Text] [Related]
40. The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer.
Kemik O; Kemik A; Sümer A; Almali N; Gurluler E; Gures N; Purisa S; Adas G; Dogan Y; Tuzun S
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2923-8. PubMed ID: 24254562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
